Genzyme Gains on Drug OK
232342
Genzyme (GENZ :Nasdaq - news - research) shares rose early Wednesday after US regulators approved its leukemia drug for children. The Food and Drug Administration Tuesday approved the drug Clolar, an intravenous
442213
THURSDAY, Sept. 21 (HealthDay News) -- Some bad news has emerged from a study of an enzyme that is a major target in the effort to find new drugs to fight Alzheimer's disease.
485103
Genzyme Corp.  said on Friday its experimental drug tolevamer, a treatment for diarrhea associated with the intestinal infection Clostridium difficile, worked no better than a standard antibiotic, sending the company's shares down more than 5 percent in early trading.
39535
Sanofi-Aventis said on Friday that U.S. regulators had approved wider use for its colon cancer drug Eloxatin, lifting shares in the world's third-largest pharmaceuticals group.
451993
Drug company faces first true competition to its enzyme replacement therapy for Gaucher disease.
764507
Biotechnology company Genzyme Corp. said Thursday that it will buy back most of the selling rights to arthritis treatment Synvisc from pharmaceutical giant Wyeth.
421111
Genzyme Corp.  said on Friday its osteoarthritis pain treatment Synvisc will retain a separate, higher reimbursement rate, after the U.S. government reversed its earlier decision to cut the rate, sending Genzyme shares higher.
572919
Biotech titan Genzyme (Nasdaq: GENZ) has its roots in the treatment of rare genetic diseases and also has a significant presence in the treatment of renal diseases and providing diagnostic testing services.
382580
Genzyme Corp. of Cambridge, Mass., agreed Thursday to buy back the sales and marketing rights for Synvisc, a pain treatment for people suffering from osteoarthritis of the knee, from Wyeth Pharmaceuticals of Collegeville, Pa.
390937
A rare bidding war between two Cambridge biotechnology powerhouses heated up yesterday after Genzyme Corp. said it might raise its offer for a Canadian drug company, hoping to snatch it away from another suitor, Millennium Pharmaceuticals Inc.
310266
Trial results for a drug that controls bleeding include a favorable comparison with a similar product.
751523
A new addition to an already successful drug promises good results for investors.
268228
Genzyme Corp. chief executive Henri A. Termeer's salary of $1.2 million last year was the highest of any in the biotechnology industry, according to a survey released yesterday.
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
93007
Kristen Galfetti&#39;s small glass office at the new headquarters of Genzyme, a producer of therapeutic drugs in Cambridge, Massachusetts, has two doors.
229274
Genentech, the biotechnology company, posted a 41 percent increase in second-quarter profit on sales of its cancer drugs, continuing a positive earnings streak.
725261
There's encouraging news about an enzyme replacement drug.